119 related articles for article (PubMed ID: 3595674)
1. Mutagenicity in urine from nurses handling cytostatic agents.
Benhamou S; Callais F; Sancho-Garnier H; Min S; Courtois YA; Festy B
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1489-93. PubMed ID: 3595674
[TBL] [Abstract][Full Text] [Related]
2. Handling of cytostatic drugs and urine mutagenesis.
Poyen D; De Méo MP; Botta A; Gouvernet J; Duménil G
Int Arch Occup Environ Health; 1988; 61(3):183-8. PubMed ID: 3220590
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.
Bos RP; Leenaars AO; Theuws JL; Henderson PT
Int Arch Occup Environ Health; 1982; 50(4):359-69. PubMed ID: 6757139
[TBL] [Abstract][Full Text] [Related]
4. Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.
DeMéo MP; Mérono S; DeBaille AD; Botta A; Laget M; Guiraud H; Duménil G
Int Arch Occup Environ Health; 1995; 66(6):363-8. PubMed ID: 7782118
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the SOS Chromotest to detect urinary mutagenicity caused by smoking.
De Méo MP; Miribel V; Botta A; Laget M; Duménil G
Mutagenesis; 1988 May; 3(3):277-83. PubMed ID: 3137423
[TBL] [Abstract][Full Text] [Related]
6. Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs.
Barale R; Sozzi G; Toniolo P; Borghi O; Reali D; Loprieno N; Della Porta G
Mutat Res; 1985; 157(2-3):235-40. PubMed ID: 4022044
[TBL] [Abstract][Full Text] [Related]
7. Comparison of methods for the biomonitoring of nurses handling antitumor drugs.
Thiringer G; Granung G; Holmén A; Högstedt B; Järvholm B; Jönsson D; Persson L; Wahlström J; Westin J
Scand J Work Environ Health; 1991 Apr; 17(2):133-8. PubMed ID: 2047815
[TBL] [Abstract][Full Text] [Related]
8. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of urine of bidi and cigarette smokers and tobacco chewers.
Menon MM; Bhide SV
Carcinogenesis; 1984 Nov; 5(11):1523-4. PubMed ID: 6488476
[TBL] [Abstract][Full Text] [Related]
10. Urinary mutagenicity tests in lead-exposed workers.
Apostoli P; Leone R; Porru S; Fracasso ME; Alessio L
Mutat Res; 1989 Mar; 222(3):245-51. PubMed ID: 2646535
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic activity of overnight urine from healthy non-smoking subjects.
Pavanello S; Lupi S; Pulliero A; Gregorio P; Saia BO; Clonfero E
Environ Mol Mutagen; 2007 Mar; 48(2):143-50. PubMed ID: 17295305
[TBL] [Abstract][Full Text] [Related]
12. Oltipraz chemoprevention trial in Qidong, People's Republic of China: results of urine genotoxicity assays as related to smoking habits.
Camoirano A; Bagnasco M; Bennicelli C; Cartiglia C; Wang JB; Zhang BC; Zhu YR; Qian GS; Egner PA; Jacobson LP; Kensler TW; De Flora S
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):775-83. PubMed ID: 11440963
[TBL] [Abstract][Full Text] [Related]
13. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
Gatehouse D; Wedd DJ
Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
[TBL] [Abstract][Full Text] [Related]
14. Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests.
Labuhn K; Valanis B; Schoeny R; Loveday K; Vollmer WM
Cancer Nurs; 1998 Apr; 21(2):79-89. PubMed ID: 9556934
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
Marzin D; Jasmin C; Maral R; Mathe G
Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
[TBL] [Abstract][Full Text] [Related]
16. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures.
Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS
Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994
[TBL] [Abstract][Full Text] [Related]
17. The use of rat urine extracted on XAD-2 resin and assayed in a microsuspension-modified Ames test as an in vivo indicator of genotoxic exposure.
Doolittle DJ; Lee DA; Rahn CA
Mutat Res; 1988 Oct; 206(2):141-8. PubMed ID: 3050496
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity studies and D-glucaric acid determination in urine of workers exposed to mineral oils.
Pasquini R; Monarca S; Sforzolini GS; Savino A; Angeli G
Int Arch Occup Environ Health; 1985; 56(4):275-84. PubMed ID: 3905625
[TBL] [Abstract][Full Text] [Related]
19. Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.
Stucker I; Hirsch A; Doloy T; Bastie-Sigeac I; Hemon D
Int Arch Occup Environ Health; 1986; 57(3):195-205. PubMed ID: 3957439
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a battery of Salmonella typhimurium tester strains for biomonitoring of mutagenic polycyclic aromatic hydrocarbons, nitroarenes and aromatic amines.
Nikoyan A; De Méo M; Sari-Minodier I; Chaspoul F; Gallice P; Botta A
Mutat Res; 2007 Jan; 626(1-2):88-101. PubMed ID: 17095286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
